PROCEPT BioRobotics CorpPRCTEarnings & Financial Report
Nasdaq
PRCT Q3 2025 Key Financial Metrics
Revenue
$83.3M
Gross Profit
$54.0M
Operating Profit
$-23.2M
Net Profit
$-21.4M
Gross Margin
64.8%
Operating Margin
-27.8%
Net Margin
-25.7%
YoY Growth
42.8%
EPS
$-0.38
Financial Flow
PROCEPT BioRobotics Corp Q3 2025 Financial Summary
PROCEPT BioRobotics Corp reported revenue of $83.3M for Q3 2025, with a net profit of $-21.4M (-25.7% margin). Cost of goods sold was $29.3M, operating expenses totaled $77.2M.
Key Financial Metrics
| Total Revenue | $83.3M |
|---|---|
| Net Profit | $-21.4M |
| Gross Margin | 64.8% |
| Operating Margin | -27.8% |
| Report Period | Q3 2025 |
PROCEPT BioRobotics Corp Annual Revenue by Year
PROCEPT BioRobotics Corp annual revenue history includes year-by-year totals (for example, 2024 revenue was $224.5M).
| Year | Annual Revenue |
|---|---|
| 2024 | $224.5M |
| 2023 | $136.2M |
| 2022 | $75.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.6M | $44.5M | $53.4M | $58.4M | $68.2M | $69.2M | $79.2M | $83.3M |
| YoY Growth | 83.3% | 82.5% | 61.2% | 66.3% | 56.6% | 55.3% | 48.4% | 42.8% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $404.7M | $382.9M | $374.4M | $374.1M | $534.0M | $519.4M | $513.1M | $511.5M |
| Liabilities | $124.0M | $118.9M | $122.6M | $132.9M | $131.8M | $130.2M | $127.3M | $131.3M |
| Equity | $280.8M | $264.0M | $251.8M | $241.2M | $402.2M | $389.2M | $385.8M | $380.3M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-24.8M | $-32.3M | $-15.7M | $-18.8M | $-32.4M | $-17.0M | $-15.0M | $-6.6M |